BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 26, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 25, 2000
View Archived Issues
ID Biomedical licenses oral E. coli vaccine technology
Read More
Long-term outcomes show good safety profile for Celebrex
Read More
Company Profile: IDM
Read More
C5 proven necessary for active arthritis; data support development of 5G1.1
Read More
Delsys develops novel solid oral dosage forms
Read More
Basulin completes proof-of-principle study
Read More
ML-3000 enters phase III trial in osteoarthritis
Read More
Ajinomoto prepares benzene derivatives useful for inflammation, etc.
Read More
Zonagen submits final results of two-year rat study of Vasomax to FDA
Read More
Millennium reports Q1 2000 progress
Read More
Prostanoid receptor ligands reported in recent patent literature by Ono
Read More
Kyorin patents new cell adhesion inhibitors
Read More
Potential new treatment for traumatic brain injury under study at Boehringer Ingelheim
Read More
Discovery of novel cytokine disclosed by Schering-Plough
Read More
Novel interferon with application in therapy discovered by ZymoGenetics
Read More
Zeria updates status of GI pipeline
Read More
Progen's angiogenesis inhibitor slows tumor growth in rats
Read More
Watanidipine advances toward launch in major Asian countries
Read More
Human data indicate potential of cefoselis in oral and maxillofacial infections
Read More
New Alzheimer's disease therapy cleared by FDA
Read More
Lipophilic platinum complex superior to cisplatin in rat hepatic tumor model
Read More
FDA approves Camptosar as first-line treatment of metastatic colorectal cancer
Read More
SafeScience's phase II trial of GBC-590 expanded
Read More
Novelos Therapeutics initiates first U.S. trial of BAM-002
Read More
